View in EDS

Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia.

Saved in:
Bibliographic Details
Title: Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia.
Authors: Waldmann TA; Metabolism Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA. tawald@helix.nih.gov, Conlon KC, Stewart DM, Worthy TA, Janik JE, Fleisher TA, Albert PS, Figg WD, Spencer SD, Raffeld M, Decker JR, Goldman CK, Bryant BR, Petrus MN, Creekmore SP, Morris JC
Source: Blood [Blood] 2013 Jan 17; Vol. 121 (3), pp. 476-84. Date of Electronic Publication: 2012 Dec 03.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Intramural
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 23212516
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Waldmann+TA%22">Waldmann TA</searchLink>; Metabolism Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA. tawald@helix.nih.gov<br /><searchLink fieldCode="AU" term="%22Conlon+KC%22">Conlon KC</searchLink><br /><searchLink fieldCode="AU" term="%22Stewart+DM%22">Stewart DM</searchLink><br /><searchLink fieldCode="AU" term="%22Worthy+TA%22">Worthy TA</searchLink><br /><searchLink fieldCode="AU" term="%22Janik+JE%22">Janik JE</searchLink><br /><searchLink fieldCode="AU" term="%22Fleisher+TA%22">Fleisher TA</searchLink><br /><searchLink fieldCode="AU" term="%22Albert+PS%22">Albert PS</searchLink><br /><searchLink fieldCode="AU" term="%22Figg+WD%22">Figg WD</searchLink><br /><searchLink fieldCode="AU" term="%22Spencer+SD%22">Spencer SD</searchLink><br /><searchLink fieldCode="AU" term="%22Raffeld+M%22">Raffeld M</searchLink><br /><searchLink fieldCode="AU" term="%22Decker+JR%22">Decker JR</searchLink><br /><searchLink fieldCode="AU" term="%22Goldman+CK%22">Goldman CK</searchLink><br /><searchLink fieldCode="AU" term="%22Bryant+BR%22">Bryant BR</searchLink><br /><searchLink fieldCode="AU" term="%22Petrus+MN%22">Petrus MN</searchLink><br /><searchLink fieldCode="AU" term="%22Creekmore+SP%22">Creekmore SP</searchLink><br /><searchLink fieldCode="AU" term="%22Morris+JC%22">Morris JC</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2013 Jan 17; Vol. 121 (3), pp. 476-84. <i>Date of Electronic Publication: </i>2012 Dec 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Intramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23212516
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood-2012-08-450585
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 476
    Titles:
      – TitleFull: Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Waldmann TA
      – PersonEntity:
          Name:
            NameFull: Conlon KC
      – PersonEntity:
          Name:
            NameFull: Stewart DM
      – PersonEntity:
          Name:
            NameFull: Worthy TA
      – PersonEntity:
          Name:
            NameFull: Janik JE
      – PersonEntity:
          Name:
            NameFull: Fleisher TA
      – PersonEntity:
          Name:
            NameFull: Albert PS
      – PersonEntity:
          Name:
            NameFull: Figg WD
      – PersonEntity:
          Name:
            NameFull: Spencer SD
      – PersonEntity:
          Name:
            NameFull: Raffeld M
      – PersonEntity:
          Name:
            NameFull: Decker JR
      – PersonEntity:
          Name:
            NameFull: Goldman CK
      – PersonEntity:
          Name:
            NameFull: Bryant BR
      – PersonEntity:
          Name:
            NameFull: Petrus MN
      – PersonEntity:
          Name:
            NameFull: Creekmore SP
      – PersonEntity:
          Name:
            NameFull: Morris JC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 01
              Text: 2013 Jan 17
              Type: published
              Y: 2013
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Numbering:
            – Type: volume
              Value: 121
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1